Historiography taking issue: Analyzing an experiment with heroin abusers

Journal of the History of the Behavioral Sciences

Volumn 40, Issue 3, 2004, Pages 247-264

  Dehue, Trudy ^a  

^a Heymans Institute   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HEROIN DEPENDENCE; HISTORY; HOSPITALIZATION; HUMAN; NETHERLANDS; RANDOMIZED CONTROLLED TRIAL; STANDARD;

HEROIN; HEROIN DEPENDENCE; HISTORIOGRAPHY; HUMANS; NETHERLANDS; RANDOMIZED CONTROLLED TRIALS; SEVERITY OF ILLNESS INDEX;

EID: 4043092126     PISSN: 00225061     EISSN: None     Source Type: Journal    
DOI: 10.1002/jhbs.20023     Document Type: Article

References (46)

1. Abraham, J. (1995). Science, politics and the pharmaceutical industry: Controversy and bias in drug regulation. London: UCL Press.
2. Anderson, W. (1991). The New York needle trial: The politics of public health in the age of AIDS. American Journal of Public Health, 81, 1506-1517.
3. Blom, H. (2002). Politick versus historie. Nederlands Instituut voor Oorlogsdocumentatie maakt onderscheid tussen moraal en wetenschap. Academische Boekengids, 3336, 4-7.
4. Bourgois, P. (2002). Anthropology and epidemiology on drugs: The challenges of cross-methodological and theoretical dialogue. International Journal of Drug Policy, 13, 259-269.
5. Brown, R. (1997). The delayed birth of social experiments. History of the Human Sciences, 10, 1-23.
6. Carrithers, D. (1995). The enlightenment science of society. In C. Fox, R. Porter, & R. Wokler (Eds.), Inventing human science. Eighteenth-century domains (pp. 232-270). Berkeley, CA: University of California Press.
7. Central Committee on the Treatment of Heroin Addicts (CCBH). (1997). Onderzoek naar Heroïne op Medisch Voorschrift. I Het Onderzoek. D. Deelnemersinformatie. Unpublished report, Utrecht, the Netherlands.
8. Central Committee on the Treatment of Heroin Addicts (CCBH). (2002). Medical co-prescription of heroin. Two randomized trials. Retrieved March 31, 2004, from http://www.ccbh.nl
9. Chalmers, I. (2001). Comparing like with like: Some historical milestones in the evolution of methods to create unbiased comparison of groups in therapeutic experiments. International Journal of Epidemiology, 30, 1156-1164.
10. Cole, S. (2001). Suspect identities: A history of fingerprinting and criminal identification. Cambridge, MA: Harvard University Press.
11. Courtwright, D. (2001). Dark paradise: A history of opiate addiction in America. Cambridge, MA: Harvard University Press.
12. Danziger, K. (1990). Constructing the subject. New York: Cambridge University Press.
13. Danziger, K. (2000). Making social psychology experimental: A conceptual history, 1920-1970. Journal of the History of the Behavioral Sciences, 26, 329-349.
14. Dehue, T. (2001). Establishing the experimenting society. American Journal of Psychology, 114, 283-302.
15. Dehue, T. (2002a). A Dutch treat. Randomized contolled experimentation and the case of heroin maintenance in the Netherlands. History of the Human Sciences, 15, 75-98.
16. Dehue, T. (2002b). Over de assumpties van RCT's, geïllustreerd aan het Nederlandse experiment met verstrekking van heroïne. Maandblad voor Geestelijke Volksgezondheid, 3, 230-249.
17. Dehue, T. (2002c). Antwoord op de brief van Minister Borst. Maandblad voor Geestelijke Volksgezondheid, 9, 806-811.
18. Dehue, T. (in press). The history of social experiments. From disturbing events to social science research designs. In K. Kempf-Leonard (Ed.), Encyclopedia of Social Measurement. New York: Academic Press.
19. de Ridder, M. (2000). Heroin. Vom Arzneimittel zur Droge. Frankfurt am Main, Campus.
20. Epstein, S. (1995). The construction of lay expertise: AIDS, activism and the forging of credibility in the reform of clinical trials. Science, Technology & Human Values, 20, 408-437.
21. Epstein, S. (1996). Impure science: AIDS, activism and the politics of knowledge. San Diego, CA: University of California Press.
22. Esping-Andersen, G. (1990). The three worlds of welfare capitalism. Cambridge: Polity Press.
23. Fisher, R. (1935). The design of experiments. Edinburgh: Oliver & Boyd.
24. Fisher, S., & Greenberg, R. P. (Eds.). (1993). The curse of the placebo: Fanciful pursuit of a pure biological therapy. New York: Wiley.
25. Hanson, B., Beschner, G., Walters, J. M., & Bovelle, E. (1985). Life with heroin: Voices from the inner city. Lexington, MA: Lexington Books.
26. Healy, D. (2001). The dilemmas posed by new and fashionable treatments. Advances in Psychiatric Treatment, 7, 322-327.
27. Jevons, W. S. (1880). Experimental legislation and the drink traffic. Contemporary Review, 7, 177-192.
28. Jevons, W. S. (1882). The state in relation to labour. London: McMillan.
29. Jones, D. S. (2000). Visions of a cure: Visualisation, clinical trials, and controversies in cardiac therapeutics, 1968-1998. Isis, 91, 504-541.
30. Kaptchuck, T. J. (1998). Intentional ignorance: A history of blind assessment and placebo controls in medicine. Bulletin of the History of Medicine, 72, 389-433.
31. Kaptchuck, T. J. (2001). The double-blind randomized, placebo-controlled trial: Gold standard or golden calf? Journal of Clinical Epidemiology, 54, 541-549.
32. Lynch, M., & Cole, S. (forthcoming). STS on trial. Dilemmas of expertise.
33. Marks, H. M. (1988). Notes from the underground: The social organization of therapeutic research. In R. C. Maulitz & D. E. Long (Eds.), Grand rounds. One hundred years of internal medicine (pp. 297-336). Philadelphia: University of Pennsylvania Press.
34. Marks, H. M. (1997). The progress of experiment: Science and therapeutic reform in the United States, 1900-1990. New York: Cambridge University Press.
35. McCall, W. A. (1923). How to experiment in education. New York: Macmillan.
36. Medawar, C. (2003). The antidepressant web: Marketing depression and making medicines work. Retrieved March 31, 2004, from www.socialaudit.org.uk.
37. Ministerie van Volksgezondheid. (2001). Voortgangsrapportage drugbeleid, September 1999-September 2001.
38. Nelkin, D., & Tancredi, L. (1994). Dangerous diagnostics: The social power of biological information. Chicago, IL: The University of Chicago Press.
39. Nye, R. A. (2003). The evolutions of the concept of medicalization in the late twentieth century. Journal of the History of the Behavioral Sciences, 39, 115-131.
40. Richards, E. (1988). The politics of therapeutic evaluation: Vitamin C and cancer. Social Studies of Science, 18, 653-701.
41. Richards, E. (1991). Vitamin C and cancer: Medicine or politics? London: Macmillan.
42. Stimson, G. V., & Metrebian, N. (2003). Prescribing heroin: What is the evidence? York: Joseph Rowntree Foundation.
43. Stone, D. A. (1993). Clinical authority in the construction of citizenship. In H. M. Ingram & S. R. Smith (Eds.), Public policy for democracy (pp. 45-68). Washington, DC: The Brookings Institution.
44. Van den Brink, W., Hendriks, V M., Blanken, P., Koeter, M. W. J., Van Zwieten, B. J., & Van Ree, J. M. (2003a). Medical prescription of heroin to treatment resistant heroin addicts: Two randomised controlled trials. British Medical Journal, 327, 310-312.
45. Van den Brink, W., Hendriks, V M., Blanken, P., Koeter, M. W. J., Van Zwieten, B. J., & Van Ree, J. M. (2003b). Correction for Van den Brink et al, BMJ, 327, 310-312. British Medical Journal, 327, 724.
46. Zinberg, N. E. (1984). Drug, set and setting: The basis for controlled intoxicant use. New Haven, CT: Yale University Press.